PHARMACEUTICAL ONCOLOGY PREPARATIONS

Brand Owner (click to sort) Address Description
ADCYTA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
BRAFIARQ GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
BRAFNEO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
BRAFYTE GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
BREFYTE GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
COBI GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
CONJUHER GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
CONJUHER GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
COTELLIC GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;The wording COTELLIC has no meaning in a foreign language.;
ENVYNZYBA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 pharmaceutical oncology preparations;
ENVYNZYBA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 pharmaceutical oncology preparations;
ERIVEDGE GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GATUZA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GATUZA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GAZYVA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GLYPTIMA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GLYPTIMA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GLYTARVA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
GLYTARVA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
HEDGESMO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
HERANEU GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
HERCYDA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
HERCYLA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
IMETRIGO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
IMETRIGO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
IMETRIGO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
IMTHELIS GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
INVISEDGE GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
LYTRECTA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations in the nature of pharmaceutical preparations for the treatment of oncological related diseases and disorders;
METALTA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;METAL TA;
METALTA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
METUMO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
METUMO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
METUMO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
OMLIAGO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 pharmaceutical oncology preparations;
OMLIAGO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 pharmaceutical oncology preparations;
PERJETA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
PLAITRA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
POLAQUEST GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
POLIVY GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
ROXILTREK GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations in the nature of pharmaceutical preparations for the treatment of oncological related diseases and disorders;
ROZLYTREK GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 pharmaceutical oncology preparations;
SUVISRA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
TECELTRIC GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
TECENTRIQ GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
TEDEMI GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
TOLPOVA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
VYZMIO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
VYZMIO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 PHARMACEUTICAL ONCOLOGY PREPARATIONS;
VYZMIO GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations in the nature of pharmaceutical preparations for the treatment of oncological related diseases and disorders;
ZELBORAF GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
ZURPOLA GENENTECH, INC. 1 DNA Way South San Francisco CA 94080 Pharmaceutical oncology preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.